The US Food and Drug Administration (FDA) regulatory process often involves several reviewers who focus on sets of information related to their respective areas of review. Accordingly, manufacturers that provide submission packages to regulatory agencies are instructed to organize the contents using a structure that enables the information to be easily allocated, retrieved, and reviewed. However, this practice is not always followed correctly; as such, some documents are not well structured, with similar information spreading across different sections, hindering the efficient access and review of all of the relevant data as a whole. To improve this common situation, we evaluated an artificial intelligence (AI)-based natural language processing (NLP) methodology, called Bidirectional Encoder Representations from Transformers (BERT), to automatically classify free-text information into standardized sections, supporting a holistic review of drug safety and efficacy. Specifically, FDA labeling documents were used in this study as a proof of concept, where the labeling section structure defined by the Physician Label Rule (PLR) was used to classify labels in the development of the model. The model was subsequently evaluated on texts from both well-structured labeling documents (i.e., PLR-based labeling) and less- or differently structured documents (i.e., non-PLR and Summary of Product Characteristic [SmPC] labeling.) In the training process, the model yielded 96% and 88% accuracy for binary and multiclass tasks, respectively. The testing accuracies observed for the PLR, non-PLR, and SmPC testing data sets for the binary model were 95%, 88%, and 88%, and for the multiclass model were 82%, 73%, and 68%, respectively. Our study demonstrated that automatically classifying free texts into standardized sections with AI language models could be an advanced regulatory science approach for supporting the review process by effectively processing unformatted documents.